| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 06/26/2013 | EP2606051A1 Pyrrolopyrimidine compounds and uses thereof |
| 06/26/2013 | EP2606050A2 Heterocyclyl pyrazolopyrimidine analogues as selective jak inhibitors |
| 06/26/2013 | EP2606045A1 Oxadiazole inhibitors of leukotriene production |
| 06/26/2013 | EP2605774A1 Molecular switch |
| 06/26/2013 | CN103180324A Coelenterazine derivatives and methods of using same |
| 06/26/2013 | CN103180323A Process for the preparation of anagrelide and analogues thereof |
| 06/26/2013 | CN103180322A Pyrazole compounds as jak inhibitors |
| 06/26/2013 | CN103180319A Inhibitors of semicarabazide - sensitive amine oxidase |
| 06/26/2013 | CN103180314A Oxadiazole inhibitors of leukotriene production |
| 06/26/2013 | CN103180313A 有机电致发光装置 Organic electroluminescent device |
| 06/26/2013 | CN103180295A 多环四环素化合物 Polycyclic tetracycline compounds |
| 06/26/2013 | CN103172641A Heterocyclic amino and alkoxy-replaced quinazoline derivative and application thereof |
| 06/26/2013 | CN103172639A Preparation method of hexahydric dicycloguanidine based on guanidine hydrochloride |
| 06/26/2013 | CN103172638A Preparation method of epinastine hydrochloride |
| 06/26/2013 | CN103172637A Pyrimido [1, 2-a] benzimidazole compound and method for preparing same |
| 06/26/2013 | CN103172636A Pyridine-quinazolinone compound and preparation method thereof |
| 06/26/2013 | CN103172635A Piperazine or piperidine compound as well as salts, intermediates, preparation method and application thereof |
| 06/26/2013 | CN103172634A Method for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizinone-5-acetic acid-4'-bromo-butyl ester |
| 06/26/2013 | CN102513154B Pyrrolidine derived imide catalyst as well as preparation method and application thereof |
| 06/26/2013 | CN101912400B 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido[2,3-d] pyrimidine derivatives and related compounds for the treatment of cancer |
| 06/25/2013 | US8471016 Process for the preparation of chiral beta amino carboxamide derivatives |
| 06/25/2013 | US8471009 (EN) 2-alkylamino-3-arylsulfonyl-cycloalcano [e OR d] pyrazolo [1,5-A]pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof |
| 06/25/2013 | US8471006 Coupling agents for peptide synthesis |
| 06/25/2013 | US8471005 Pyrrolotriazines as ALK and JAK2 inhibitors |
| 06/25/2013 | US8470837 MAPK/ERK kinase inhibitors |
| 06/25/2013 | US8470836 Dipeptidyl peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent |
| 06/25/2013 | US8470812 Substituted benzo-pyrimido-tetrazolo-diazepine compounds |
| 06/25/2013 | CA2744714C Amino pyrazole compound |
| 06/25/2013 | CA2551611C Thiazole derivatives for treating or preventing parkinson's disease |
| 06/20/2013 | WO2013090912A1 Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis |
| 06/20/2013 | WO2013090547A1 Malonic acid di-salts and a method for preparing malonyl dihalides |
| 06/20/2013 | WO2013090490A1 Tofacitinib salts |
| 06/20/2013 | WO2013088973A1 Organic electroluminescent element |
| 06/20/2013 | WO2013087647A1 Substituted benzothienyl - pyrrolotriazines and uses thereof in the treatment cancer |
| 06/20/2013 | WO2013087578A1 Disubstituted benzothienyl-pyrrolotriazines and their use as fgfr kinase inhibitors |
| 06/20/2013 | WO2013086804A1 4-pyridyl porphyrin bridged crisscross quad-nuclear platinum complex, and preparation method and anti-tumor activity thereof |
| 06/20/2013 | WO2013033268A3 Bivalent bromodomain ligands, and methods of using same |
| 06/20/2013 | WO2013020164A9 Compounds for treating respiratory syncytial virus infections |
| 06/20/2013 | US20130158265 Sitagliptin, salts and polymorphs thereof |
| 06/20/2013 | US20130158264 Polymorphs of OSI-906 |
| 06/20/2013 | US20130158259 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/20/2013 | US20130158258 2-aminopyrimidine modulators of the histamine h4 receptor |
| 06/20/2013 | US20130158042 Novel compounds |
| 06/20/2013 | US20130158040 Diazaindole inhibitors of crac |
| 06/20/2013 | US20130158037 Compounds and methods for treating tuberculosis infection |
| 06/20/2013 | US20130158025 Novel compound acting as a cannabinoid receptor-1 inhibitor |
| 06/20/2013 | US20130158021 Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof |
| 06/20/2013 | US20130158018 Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S |
| 06/20/2013 | US20130158003 Heteroaryl compounds and methods of use thereof |
| 06/20/2013 | US20130158001 Substituted 3-phenyl-1,2,4-oxadiazole compounds |
| 06/20/2013 | US20130158000 Disubstituted benzothienyl-pyrrolotriazines and uses thereof |
| 06/20/2013 | US20130157999 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/20/2013 | US20130157996 Trpm8 antagonists and their use in treatments |
| 06/20/2013 | US20130157989 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof |
| 06/20/2013 | US20130156851 Lipomacrocycles and uses thereof |
| 06/20/2013 | CA2857333A1 Malonic acid di-salts and a method for preparing malonyl dihalides |
| 06/19/2013 | EP2604611A1 N-Biaryl substituted diazabicycloalkane derivatives as agonists of the alpha7 and alpha4beta2 nACh Receptor |
| 06/19/2013 | EP2604610A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof |
| 06/19/2013 | EP2604609A1 Aildenafil citrate crystal form o, preparation method and use thereof |
| 06/19/2013 | EP2603511A1 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d]pyrimidin-4-one derivatives and their use as pde9a inhibitors |
| 06/19/2013 | EP2603504A1 Hepatitis c virus inhibitors |
| 06/19/2013 | EP2603500A1 Inhibitors of bruton's tyrosine kinase |
| 06/19/2013 | CN103168042A 7-((1,2,3)Triazol-4-yl)-pyrrolo(2,3) pyrazinderivate |
| 06/19/2013 | CN103168041A 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof |
| 06/19/2013 | CN103159771A Technique for synthesizing porphyrin-functionalized cobalt oxide nanoparticles by one-step method |
| 06/19/2013 | CN103159745A Compound used on organic electroluminescent device and organic electroluminescent device |
| 06/19/2013 | CN102643765B Streptomyces, anti-tumor compound (Spiro-Indimycin A-D) as well as preparation method and application thereof |
| 06/19/2013 | CN102321089B Screw ring alkaloid compound, preparation method thereof and application in the aspect of marine organism fouling resistance |
| 06/19/2013 | CN101962536B Lysosome targeted fluorescent substance and synthesis method thereof |
| 06/19/2013 | CN101880276B Substituted diazepan compounds as orexin receptor antagonists |
| 06/19/2013 | CN101874021B Azaindenofluorenedione derivative, organic electroluminescent device material, and organic electroluminescent device |
| 06/19/2013 | CN101627027B 氨基吡唑激酶抑制剂 Aminopyrazole kinase inhibitors |
| 06/19/2013 | CN101605764B Fast dissociating dopamine 2 receptor antagonists |
| 06/19/2013 | CN101594871B Pyrrolopyrimidine compounds and their uses |
| 06/18/2013 | US8466164 4-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof |
| 06/18/2013 | US8466152 (aza)indole derivative and use thereof for medical purposes |
| 06/18/2013 | US8466143 Azepine derivatives as pharmaceutical agents |
| 06/18/2013 | CA2683695C 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives |
| 06/18/2013 | CA2566898C Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 06/13/2013 | WO2013085954A1 Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors |
| 06/13/2013 | WO2013085850A2 Stereoselective total synthesis of noribogaine |
| 06/13/2013 | WO2013085849A2 Sulfate esters of noribogaine |
| 06/13/2013 | WO2013085802A1 Pyrrolopyrimidines as janus kinase inhibitors |
| 06/13/2013 | WO2013085339A2 Organic light-emitting compound and organic electroluminescent device using same |
| 06/13/2013 | WO2013084835A1 Organic semiconductor material and organic electronic devices |
| 06/13/2013 | WO2013084805A1 Nitrogen-containing aromatic compound, organic semiconductor material and organic electronic devices |
| 06/13/2013 | WO2013084210A1 Amorphous form of sitagliptin salts |
| 06/13/2013 | WO2013083666A1 Inhibitors of bruton's tyrosine kinase |
| 06/13/2013 | WO2013083591A1 Substituted pyrazoles as mglu5 receptor modulators |
| 06/13/2013 | WO2013082656A1 Cage amine ligands for metallo-radiopharmaceuticals |
| 06/13/2013 | WO2013082655A1 Functionalisation of cage amine ligands for metallo-radiopharmaceuticals |
| 06/13/2013 | WO2012177893A3 Trpm8 antagonists and their use in treatments |
| 06/13/2013 | US20130150578 Novel hypoglycemic compounds |
| 06/13/2013 | US20130150572 Phosphinate ruthenium complexes |
| 06/13/2013 | US20130150380 Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd |
| 06/13/2013 | US20130150371 Inhibitors of PDE10 |
| 06/13/2013 | US20130150364 Heterocyclic compound |
| 06/13/2013 | US20130150362 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| 06/13/2013 | US20130150360 Inhibitors of bruton's tyrosine kinase |
| 06/13/2013 | US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers |